Security key
088786108
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC)
CUSIP: 088786108
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
- Total 13F shares
- 30,475,266
- Total 13F value
- $758,677,656
- Share change
- -860,729
- Put/Call ratio
- 75%
- SEC-reported price per share
- $24.90
- Number of holders
- 93
- Value change
- +$6,974,793
- Number of buys
- 41
- Number of sells
- 47
- Shares outstanding
- 50,340,741
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
93
Top holders
10
BCYC full security history
Ownership snapshot
Full 13F holder table
BICYCLE THERAPEUTICS PLC SEC filings
BICYCLE THERAPEUTICS PLC company facts
Broader feeds
Ownership snapshot
Top reported holders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Paradigm Biocapital Advis...
Disclosed value leader
Paradigm Biocapital Advis...
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
Paradigm Biocapital Advisors LP leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Paradigm Biocapital Advisors LP's linked filing trail.
Comparable ownership
Top 5
Paradigm Biocapital Advisors LP
7.4%
Deep Track Capital, LP
6.9%
Jefferies Financial Group Inc.
3.9%
BAKER BROS. ADVISORS LP
3.6%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP |
13F
Company
|
7.4%
|
$67,022,578
3,707,001 shares
|
— | 31 Dec 2023 |
| Deep Track Capital, LP |
13F
Company
|
6.9%
|
$63,108,348
3,490,506 shares
|
— | 31 Dec 2023 |
| Jefferies Financial Group Inc. |
13F
Company
|
3.9%
|
$35,219,840
1,948,000 shares
|
— | 31 Dec 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
3.6%
|
$32,370,251
1,790,390 shares
|
— | 31 Dec 2023 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
Company
|
3.3%
|
$29,837,786
1,650,320 shares
|
— | 31 Dec 2023 |
| First Light Asset Management, LLC |
13F
Company
|
3.1%
|
$28,032,516
1,550,471 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
93
Shares
30,475,266
Rows available
93
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
93
Q1 2024 holders
93
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|